Ferring licenses elobixibat from Albireo for Chronic Constipation and IBS. - 06-Jul-2012

Ferring has licensed from Albireo the world rights to elobixibat, excluding those territories held by Ajimoto. Elobixibat is a first-in-class investigational drug in development for Chronic Constipation and Irritable Bowel Syndrome with Constipation.

Related News

Related Gastroenterology Information

Related Gastroenterology Drugs

Back to top

Latest News

10 May 2015
18 May 2013
18 May 2013